No abstract available
MeSH terms
-
Angiogenesis Inhibitors / metabolism
-
Angiogenesis Inhibitors / pharmacology*
-
Animals
-
Atherosclerosis / drug therapy*
-
Atherosclerosis / metabolism
-
Atherosclerosis / pathology
-
Atorvastatin
-
Carbocyanines / metabolism
-
Cyclohexanes / metabolism
-
Cyclohexanes / pharmacology*
-
Drug Carriers
-
Drug Synergism
-
Drug Therapy, Combination
-
Fatty Acids, Unsaturated / metabolism
-
Fatty Acids, Unsaturated / pharmacology*
-
Heptanoic Acids / pharmacology
-
Heterocyclic Compounds, 1-Ring / metabolism
-
Humans
-
Integrin alphaVbeta3 / metabolism
-
Magnetic Resonance Imaging
-
Nanoparticles
-
Neovascularization, Pathologic / metabolism
-
Neovascularization, Pathologic / pathology
-
Neovascularization, Pathologic / prevention & control*
-
Pyrroles / pharmacology
-
Sesquiterpenes / metabolism
-
Sesquiterpenes / pharmacology
-
Time Factors
Substances
-
Angiogenesis Inhibitors
-
Carbocyanines
-
Cyclohexanes
-
Drug Carriers
-
Fatty Acids, Unsaturated
-
Heptanoic Acids
-
Heterocyclic Compounds, 1-Ring
-
Integrin alphaVbeta3
-
Pyrroles
-
Sesquiterpenes
-
TA 145
-
fumagillin
-
Atorvastatin